Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Bluebird bio stock

Learn how to easily invest in Bluebird bio stock.

Bluebird bio Inc is a biotechnology business based in the US. Bluebird bio shares (BLUE) are listed on the NASDAQ and all prices are listed in US Dollars. Bluebird bio employs 518 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Bluebird bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BLUE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Bluebird bio stock price (NASDAQ: BLUE)

Use our graph to track the performance of BLUE stocks over time.

Bluebird bio shares at a glance

Information last updated 2022-07-02.
Latest market close$4.28
52-week range$2.87 - $20.55
50-day moving average $3.68
200-day moving average $7.70
Wall St. target price$7.33
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-10.43

Buy Bluebird bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Bluebird bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bluebird bio price performance over time

Historical closes compared with the close of $4.28 from 2022-07-01

1 week (2022-06-24) -2.73%
1 month (2022-06-01) 44.11%
3 months (2022-03-31) -11.75%
6 months (2021-12-31) -57.16%
1 year (2021-07-02) -86.36%
2 years (2020-07-02) -92.81%
3 years (2019-07-02) 127.8
5 years (2017-06-30) 104.9979

Is Bluebird bio stock undervalued or overvalued?

Valuing Bluebird bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bluebird bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bluebird bio's PEG ratio

Bluebird bio's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bluebird bio's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Bluebird bio financials

Revenue TTM $4.7 million
Gross profit TTM $-351,136,000
Return on assets TTM -31.44%
Return on equity TTM -76.97%
Profit margin 0%
Book value $3.69
Market capitalisation $305.8 million

TTM: trailing 12 months

Bluebird bio share dividends

We're not expecting Bluebird bio to pay a dividend over the next 12 months.

Have Bluebird bio's shares ever split?

Bluebird bio's shares were split on a 1544:1000 basis on 4 November 2021. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1544 shares. This wouldn't directly have changed the overall worth of your Bluebird bio shares – just the quantity. However, indirectly, the new 35.2% lower share price could have impacted the market appetite for Bluebird bio shares which in turn could have impacted Bluebird bio's share price.

Bluebird bio share price volatility

Over the last 12 months, Bluebird bio's shares have ranged in value from as little as $2.87 up to $20.5533. A popular way to gauge a stock's volatility is its "beta".

BLUE.US volatility(beta: 1.69)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bluebird bio's is 1.6887. This would suggest that Bluebird bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Bluebird bio overview

bluebird bio, Inc. , a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc. , and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc.

Frequently asked questions

What percentage of Bluebird bio is owned by insiders or institutions?
Currently 1.191% of Bluebird bio shares are held by insiders and 92.596% by institutions.
How many people work for Bluebird bio?
Latest data suggests 518 work at Bluebird bio.
When does the fiscal year end for Bluebird bio?
Bluebird bio's fiscal year ends in December.
Where is Bluebird bio based?
Bluebird bio's address is: 60 Binney Street, Cambridge, MA, United States, 02142
What is Bluebird bio's ISIN number?
Bluebird bio's international securities identification number is: US09609G1004
What is Bluebird bio's CUSIP number?
Bluebird bio's Committee on Uniform Securities Identification Procedures number is: 09609G100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site